## CHRW: C.H. Robinson Worldwide, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 2.3% below STRENGTH zone (4.0-10.0%); PEG 2.32 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($157.17)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 2, Bearish: 1)

**1. Voya Investment Management LLC Has $10.98 Million Stock Holdings in C.H. Robinson Worldwide, Inc. $CHRW**
- Source: MarketBeat | 20251223T134049 | Bullish | Relevance: 100%
- Voya Investment Management LLC significantly increased its stake in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) during the third quarter, boosting its holdings by 126.3% to 82,941 shares valued at $10.98 million. This comes as C.H. Robinson reported better-than-expected Q3 EPS of $1.40, a dividend increase to $0.63 per share, and received a "Moderate Buy" consensus rating from analysts with an average price target of $147.48. Despite recent insider stock sales totaling approximately $14.3 million, institutional investors and hedge funds collectively own 93.15% of the company's stock.

**2. Exchange Traded Concepts LLC Has $11.66 Million Holdings in C.H. Robinson Worldwide, Inc. $CHRW**
- Source: MarketBeat | 20251223T094355 | Bullish | Relevance: 100%
- Exchange Traded Concepts LLC significantly increased its stake in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) during the third quarter, now holding shares valued at $11.66 million. This comes amidst several analyst upgrades and an increased dividend payout, though company insiders have recently sold off a substantial number of shares.

**3. Thrivent Financial for Lutherans Boosts Holdings in C.H. Robinson Worldwide, Inc. $CHRW**
- Source: MarketBeat | 20251221T110738 | Somewhat-Bullish | Relevance: 100%
- Thrivent Financial for Lutherans has significantly increased its stake in C.H. Robinson Worldwide, Inc. by 865.4%, bringing its total holdings to 47,015 shares valued at $4.51 million. This comes despite insider sell-offs from two executives, Angela K. Freeman and Michael D. Castagnetto, who collectively reduced their positions by over 40%. Analysts currently rate C.H. Robinson Worldwide as a "Moderate Buy" with an average price target of $147.48, and the company recently raised its quarterly dividend to $0.63.

**4. Is It Too Late To Consider C.H. Robinson After Its Strong 2025 Share Price Rally?**
- Source: Yahoo Finance | 20251222T100906 | Bearish | Relevance: 100%
- C.H. Robinson Worldwide has seen significant share price growth in 2025, outpacing the market, driven by optimism around freight efficiency and digital logistics. However, valuation checks suggest the stock is currently overvalued, with its DCF analysis indicating a 14.2% overvaluation and its PE ratio sitting well above industry averages and its proprietary Fair Ratio. Investors are encouraged to consider different "Narratives" for valuation to align with their own views on the company's future.

**5. Gartner debuts 4PL Magic Quadrant as tariffs and disruption reshape logistics**
- Source: Yahoo Finance | 20251223T053000 | Somewhat-Bullish | Relevance: 75%
- Gartner has released its inaugural Magic Quadrant for Fourth-Party Logistics (4PL), highlighting how orchestration, accountability, and integration are transforming supply chain management amidst persistent disruption from tariffs and geopolitics. The report positions companies like C.H. Robinson, RXO, GEODIS, Arvato, Kuehne+Nagel, 4flow, and DHL Supply Chain as leaders, while also identifying Challengers like Unilog and Visionaries such as Redwood Logistics. This new evaluation emphasizes a shift from traditional 3PL services towards comprehensive end-to-end supply chain orchestration.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Stifel | $184 | $155 | +19% |
| 2025-12-16 | Barclays | $200 | $145 | +38% |
| 2025-12-08 | Morgan Stanley | $85 | $77 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Stifel | main | Buy |
| 2025-12-16 | Barclays | up | Overweight |
| 2025-12-08 | Morgan Stanley | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 4 ($1.86M) |
| Sells | 2 ($0.38M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 54.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.0% (-3.0%)
- First Eagle Investme: 8.9% (-0.2%)
- Blackrock Inc.: 8.2% (-8.5%)
- Wellington Managemen: 6.1% (+198.6%)
- State Street Corpora: 5.8% (-7.4%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 3 raises (avg +22%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.32 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 34%). Analyst sentiment positive (3 raises, avg +22%). Insider buying signal ($1.9M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.4B |
| Beta | 0.91 |
| 52W Range | $84.68 - $167.90 |
| Short Interest | 7.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.32 |
| Forward P/E | 27.5 |
| Current P/E | 33.0 |
| YoY Growth | 20.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 4.4% to 2.3% (-2.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.7pp (needs >4.0% for momentum thesis). MRS_5 (-1.3%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 3.4% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). Elevated volume (1.6x 20MA), institutional activity likely. OFD pattern: -SBL (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.31% (CS: 77) | Neutral |
| RSI_14 | 65.3 | Neutral |
| MACD Histogram | 0.23 | Bullish |
| vs SMA20 | 1.032x | Above |
| vs SMA50 | 1.104x | Above |
| vs SMA200 | 1.404x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $164.59
- **Stop Loss:** $157.17 (4.5% risk)
- **Target:** $172.01 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 121
- **Position Value:** $19,915.39
- **Portfolio %:** 19.92%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-01-28 (Est: $1.13)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.30 | $1.40 | +7.4% |
| 2025Q2 | $1.16 | $1.29 | +11.6% |
| 2025Q1 | $1.05 | $1.17 | +11.4% |
| 2024Q4 | $1.11 | $1.21 | +9.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*